Answer
It is a combination direct-acting antiviral licensed to treat chronic hepatitis C in adults and children aged 3 years and older.
Sources for this answer
- Glecaprevir/Pibrentasvir 100 mg/40 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
- Glecaprevir/Pibrentasvir 50 mg/20 mg coated granules in sachet — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.